Skip to main content
SpringerLink
Log in

Digitalis-Therapie erhöht Sterberisiko

Herzinsuffizienz

  • Medizin
  • Published:
CME Aims and scope

Neue Studien wecken Zweifel am Nutzen von Digoxin bei Herzinsuffizienz. Danach scheint das Herzglykosid im Kontext der heutigen Standardmedikation sogar mit einem erhöhten Sterberisiko assoziiert zu sein.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Freeman JV et al, Circ Cardiovasc Qual Outcomes 2013

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    ob

Authors
  1. ob
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

ob Digitalis-Therapie erhöht Sterberisiko. CME 10, 4 (2013). https://doi.org/10.1007/s11298-013-0993-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11298-013-0993-3

Search

Navigation